Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study.

Melzer Cohen, Cheli; Thorsted, Brian Larsen; Wolden, Michael Lyng; Chodick, Gabriel; Karasik, Avraham

Melzer Cohen, Cheli; Thorsted, Brian Larsen; Wolden, Michael Lyng; Chodick, Gabriel; Karasik, Avraham.

Afiliación

Melzer Cohen C; Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel.
Thorsted BL; Novo Nordisk A/S, Søborg, Denmark.
Wolden ML; Novo Nordisk A/S, Søborg, Denmark.
Chodick G; Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel.
Karasik A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Diabetes Ther ; 8(5): 1047-1055, 2017 Oct.

Article en En | MEDLINE | ID: mdl-28884311

Palabras clave

Basal; Degludec; Dose; Glycemic control; Insulin; Real-world data

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Diabetes Ther Año: 2017 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google